Ferruccio Ceriotti Selected Research

Ferruccio Ceriotti Research Topics

Disease

11	COVID-19 05/2022 - 10/2020
6	Infections 01/2022 - 01/2021
4	Acute Kidney Injury (Acute Renal Failure) 05/2022 - 01/2012
4	Fibrosis (Cirrhosis) 01/2022 - 10/2019
4	Prostatic Neoplasms (Prostate Cancer) 07/2021 - 08/2011
3	Neoplasms (Cancer) 01/2022 - 07/2013
3	Hypertension (High Blood Pressure) 11/2021 - 09/2003
3	Acute Coronary Syndrome 01/2020 - 08/2017
2	Sepsis (Septicemia) 05/2022 - 11/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2020
2	Hypersensitivity (Allergy) 12/2021 - 09/2021
2	Liver Diseases (Liver Disease) 11/2021 - 12/2007
2	Unstable Angina 12/2020 - 08/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2017
2	Hypercholesterolemia 05/2017 - 06/2016
2	Atherosclerotic Plaque (Atheroma) 05/2017 - 06/2016
2	Hemoglobinopathies 09/2016 - 03/2016
1	Pneumonia (Pneumonitis) 05/2022
1	Septic Shock (Toxic Shock Syndrome) 05/2022
1	HIV Infections (HIV Infection) 02/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Viremia 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2022
1	Hepatitis C 01/2022
1	Bruton type agammaglobulinemia 01/2022
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Hepatitis B 12/2021
1	Urticaria (Hives) 09/2021
1	Angioedema 09/2021
1	Reinfection 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2020
1	Hyperandrogenism 12/2020
1	Myocardial Infarction 12/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2020
1	Respiratory Insufficiency (Respiratory Failure) 10/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Thrombosis (Thrombus) 01/2020

Drug/Important Bio-Agent (IBA)

6	Immunoglobulin G (IgG)IBA 05/2022 - 05/2004
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
4	AntibodiesIBA 05/2022 - 12/2018
4	Prostate-Specific Antigen (Semenogelase)IBA 07/2021 - 08/2011
3	VaccinesIBA 02/2022 - 01/2021
3	BNT162 VaccineIBA 01/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 10/2019
3	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 12/2007
3	Troponin T (Troponin T1)IBA 02/2021 - 09/2018
3	TroponinIBA 02/2021 - 01/2020
2	Immunoglobulin M (IgM)IBA 05/2022 - 12/2021
2	EnzymesIBA 05/2022 - 02/2002
2	COVID-19 VaccinesIBA 01/2022 - 09/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 12/2021
2	Biological ProductsIBA 01/2022 - 11/2018
2	acarboxyprothrombin (PIVKA)IBA 01/2022 - 01/2020
2	Vitamin K FDA Link 01/2022 - 01/2020
2	Antihypertensive Agents (Antihypertensives)IBA 12/2021 - 09/2003
2	Ferritins (Ferritin)IBA 11/2021 - 01/2021
2	Tenofovir (Viread)FDA Link 10/2019 - 10/2019
2	CholesterolIBA 05/2017 - 06/2016
2	Lipocalin-2IBA 01/2014 - 01/2012
2	AlbuminsIBA 12/2007 - 09/2003
1	Nucleocapsid ProteinsIBA 05/2022
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 05/2022
1	proadrenomedullinIBA 05/2022
1	AntigensIBA 04/2022
1	2019-nCoV Vaccine mRNA-1273IBA 02/2022
1	CA-125 Antigen (CA 125 Antigen)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	InterferonsIBA 01/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	bulevirtideIBA 01/2022
1	Prothrombin (Factor II)IBA 01/2022
1	venetoclaxIBA 01/2022
1	Keratin-19 (Keratin 19)IBA 01/2022
1	ruxolitinibIBA 01/2022
1	Hepatitis C AntibodiesIBA 12/2021
1	Anti-Idiotypic AntibodiesIBA 12/2021
1	Alanine Transaminase (SGPT)IBA 11/2021
1	LipidsIBA 11/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2021
1	BradykininIBA 09/2021
1	Peptides (Polypeptides)IBA 09/2021
1	Messenger RNA (mRNA)IBA 09/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	AndrogensIBA 12/2020
1	Androstenedione (4 Androstene 3,17 dione)IBA 12/2020
1	Testosterone (Sustanon)FDA Link 12/2020
1	ABO Blood-Group SystemIBA 10/2020
1	Lipoprotein(a)IBA 01/2020

Therapy/Procedure

4	Therapeutics 01/2022 - 10/2019
1	Length of Stay 05/2022
1	Contraindications 01/2022